Hidalgo-Tenorio, C.; Vinuesa, D.; García-Vallecillos, C.; Muñoz-Medina, L.; Sequera, S.; Javier, R.; López-Ruz, M.Á.; Sadyrbaeva-Dolgova, S.; Pasquau, J.
Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV. Viruses 2022, 14, 2626.
https://doi.org/10.3390/v14122626
AMA Style
Hidalgo-Tenorio C, Vinuesa D, García-Vallecillos C, Muñoz-Medina L, Sequera S, Javier R, López-Ruz MÁ, Sadyrbaeva-Dolgova S, Pasquau J.
Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV. Viruses. 2022; 14(12):2626.
https://doi.org/10.3390/v14122626
Chicago/Turabian Style
Hidalgo-Tenorio, Carmen, David Vinuesa, Coral García-Vallecillos, Leopoldo Muñoz-Medina, Sergio Sequera, Rosario Javier, Miguel Ángel López-Ruz, Svetlana Sadyrbaeva-Dolgova, and Juan Pasquau.
2022. "Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV" Viruses 14, no. 12: 2626.
https://doi.org/10.3390/v14122626
APA Style
Hidalgo-Tenorio, C., Vinuesa, D., García-Vallecillos, C., Muñoz-Medina, L., Sequera, S., Javier, R., López-Ruz, M. Á., Sadyrbaeva-Dolgova, S., & Pasquau, J.
(2022). Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV. Viruses, 14(12), 2626.
https://doi.org/10.3390/v14122626
